ICD-10 Coding for MRSA Bacteremia(A41.02, A41.02B, A41.02S)
Learn how to accurately code MRSA bacteremia using ICD-10, including key codes A41.02 and A49.02, and documentation requirements.
Complete code families applicable to MRSA Bacteremia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| A41.02 | Sepsis due to Methicillin resistant Staphylococcus aureus | Use when MRSA bacteremia has progressed to sepsis. |
|
| R78.81 | Bacteremia | Use when MRSA is present in the blood without sepsis. |
|
| A49.02 | Methicillin resistant Staphylococcus aureus infection, unspecified site | Use when MRSA infection is confirmed but the site is unspecified. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMRSA Bacteremia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting MRSA Bacteremia.
Documenting 'bacteremia' without specifying MRSA
Impact
Clinical: Potential misdiagnosis or under-treatment., Regulatory: Non-compliance with documentation standards., Financial: Incorrect coding leading to reimbursement issues.
Mitigation
Always specify the organism in documentation.
Using R78.81 as a principal diagnosis
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use A49.02 as the principal diagnosis with R78.81 as secondary.
Incorrect Principal Diagnosis
Impact
Using R78.81 as a principal diagnosis instead of A49.02 or A41.02.
Mitigation
Ensure correct sequencing and use of codes based on clinical documentation.